Neurocrine Biosciences, Inc. (NBIX)

132.47 +0.87 (+0.66%) USD  |  NASDAQ  |  Apr 06, 16:00
132.47 0.00 (0.00%) After-Hours: 19:37
More

Neurocrine Biosciences SG&A Expense (TTM) : 1.156B for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Glaukos Corp. 331.75M
Edgewise Therapeutics, Inc. 40.02M
Nuvalent, Inc. 107.34M
Agenus, Inc. 54.39M
Curis, Inc. 14.05M